Oil prices up on storm-hit US output and Covid-19 treatment hopes

Brent crude was up 53 cents, or 1.2%, at $44.88 a barrel by 11:22 a.m. EDT (1522 GMT). U.S. West Texas Intermediate crude rose 28 cents, or 0.7%, to $42.62

Oil & gas, rig
Energy companies shut more than 1 million barrels per day (bpd) of offshore crude oil production in the US Gulf of Mexico because of the twin threat from Hurricane Marco and Tropical Storm Laura
Laila Kearney | Reuters New York
2 min read Last Updated : Aug 24 2020 | 10:08 PM IST
Oil prices strengthened on Monday as storms threatening the Gulf of Mexico shut more than half of the region's oil production and on expectations of progress in the development of a Covid-19 treatment.
 
Brent crude was up 53 cents, or 1.2%, at $44.88 a barrel by 11:22 a.m. EDT (1522 GMT). US West Texas Intermediate crude rose 28 cents, or 0.7%, to $42.62.
 
"Prices are taking their cues from Mother Nature this morning as two storms bear down on the Gulf of Mexico. Half of the region's production has been shut down, though gains will be limited by the threat of a second prolonged Covid wave," said Stephen Brennock of oil broker PVM.
 
Energy companies shut more than 1 million barrels per day (bpd) of offshore crude oil production in the US Gulf of Mexico because of the twin threat from Hurricane Marco and Tropical Storm Laura. Workers have been evacuated from more than 100 production platforms.
 
"The much larger pricing impact off of the storm factor is falling on the product markets since refinery activity in the Texas and Louisiana region could be significantly reduced due to flooding," Jim Ritterbusch, of Ritterbusch and Associates, said in a note.
Motiva Enterprises may shut the largest crude oil refinery in the United States for the bad weather later this week, according to sources.
 
US gasoline futures were up more than 5%.
 
Also supporting oil prices was a report by the Financial Times that US President Donald Trump is considering fast-tracking an experimental Covid-19 vaccine being developed by AstraZeneca and Oxford University.
 
On Sunday Trump hailed FDA authorisation of a coronavirus treatment that uses blood plasma from recovered patients, a day after he accused the agency of impeding the rollout of vaccines and therapeutics for political reasons.
 
The World Health Organization, however, was cautious about endorsing the treatment, citing "low quality" evidence that it works.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCrude Oil PricesUS economy

Next Story